官方服务：
资源简介：
CaSR modulator in neuroblastoma model
应用场景：
创建时间：
2016-03-30
相关数据集
SAM Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
Protein arginine methyltransferase 5 (PRMT5) over-expression in hematological and solid tumors methylates arginine residues on cellular proteins involved in important cancer functions including cell c
NIAID Data Ecosystem90
Subsequent treatments after progression on CDK 4/6 inhibitors.
Subsequent treatments after progression on CDK 4/6 inhibitors.
NIAID Data Ecosystem70
Table_1_Fusion Genes Altered in Adult Malignant Gliomas.DOC
Malignant gliomas are highly heterogeneous brain tumors in molecular genetic background. Despite the many recent advances in the understanding of this disease, patients with adult high-grade gliomas r
NIAID Data Ecosystem40
肿瘤靶分子临床研究信息数据集
聚焦肿瘤靶分子临床研究全流程，整合靶点发现、临床试验设计、疗效数据、安全性评估等核心信息。数据经标准化清洗与专业校验，关联靶点分子结构、作用机制及临床结果，支持科研机构靶点验证、药企药物研发、临床机构方案优化，为靶分子临床转化提供高质量、可溯源的数据支撑。
江苏数据交易所80
Successful BRAF/MEK-inhibition in a young patient with BRAF V600E-mutated extrapancreatic acinar cell carcinoma (HIPO-021)
Pancreatic acinar cell carcinoma (PAC) is a rare but dismal disease with a peak incidence rate around 60 to 70 years of age. Treatment options in case of metastatic disease are limited and often follo
NIAID Data Ecosystem50
